State Drug Price Transparency Reporting Legislative Update: Florida Joins the Bandwagon and Minnesota Adds Onerous New Requirements

As their 2023 sessions draw to a close, mostly part-time state legislatures have continued their efforts throughout the spring to promote drug price transparency across the prescription drug supply chain. Notable among these efforts is Florida’s recent enactment of a sweeping drug price transparency act, targeting prescription drug manufacturers and pharmacy benefit managers (PBMs), and the response of the Minnesota state legislature to the state’s publication of its first annual prescription…
By: Morgan Lewis